X-ray Crystal Structure and Binding Mode Analysis of Human S-Adenosylhomocysteine Hydrolase Complexed with Novel Mechanism-Based Inhibitors, Haloneplanocin A Analogues
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Kang Man | - |
dc.contributor.author | Choi, Won Jun | - |
dc.contributor.author | Lee, Yoonji | - |
dc.contributor.author | Lee, Hyun Joo | - |
dc.contributor.author | Zhao, Long Xuan | - |
dc.contributor.author | Lee, Hyuk Woo | - |
dc.contributor.author | Park, Jae Gyu | - |
dc.contributor.author | Kim, Hea Ok | - |
dc.contributor.author | Hwang, Kwang Yeon | - |
dc.contributor.author | Heo, Yong-Seok | - |
dc.contributor.author | Choi, Sun | - |
dc.contributor.author | Jeong, Lak Shin | - |
dc.date.accessioned | 2021-09-07T14:55:09Z | - |
dc.date.available | 2021-09-07T14:55:09Z | - |
dc.date.created | 2021-06-14 | - |
dc.date.issued | 2011-02-24 | - |
dc.identifier.issn | 0022-2623 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/113044 | - |
dc.description.abstract | The X-ray crystal structure of human S-adenosylhomocysteine (AdoHcy) hydrolase was first determined as a tetrameric form bound with the novel mechanism-based inhibitor fluoroneplanocin A (4b). The crystallized enzyme complex showed the closed conformation and turned out to be the intermediate of mechanism-based inhibition. It confirmed that the cofactor depletion by 3'-oxidation of fluoroneplanocin A contributes to the enzyme inhibition along with the irreversible covalent modification of AdoHcy hydrolase. In addition, a series of haloneplanocin A analogues (4b-e and 5b-e) were designed and synthesized to characterize the binding role and reactivity of the halogen substituents and the 4'-CH2OH group. The biological evaluation and molecular modeling studies identified the key pharmacophores and structural requirements for the inhibitor binding of AdoHcy hydrolase. The inhibitory activity was decreased as the size of the halogen atom increased and/or if the 4'-CH2OH group was absent. These results could be utilized to design new therapeutic agents operating via AdoHcy hydrolase inhibition. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | AMER CHEMICAL SOC | - |
dc.subject | L-HOMOCYSTEINE HYDROLASE | - |
dc.subject | CARBOCYCLIC NUCLEOSIDES | - |
dc.subject | BIOLOGICAL EVALUATION | - |
dc.subject | DESIGN | - |
dc.subject | TARGET | - |
dc.title | X-ray Crystal Structure and Binding Mode Analysis of Human S-Adenosylhomocysteine Hydrolase Complexed with Novel Mechanism-Based Inhibitors, Haloneplanocin A Analogues | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Hwang, Kwang Yeon | - |
dc.identifier.doi | 10.1021/jm1010836 | - |
dc.identifier.scopusid | 2-s2.0-79951844831 | - |
dc.identifier.wosid | 000287338200002 | - |
dc.identifier.bibliographicCitation | JOURNAL OF MEDICINAL CHEMISTRY, v.54, no.4, pp.930 - 938 | - |
dc.relation.isPartOf | JOURNAL OF MEDICINAL CHEMISTRY | - |
dc.citation.title | JOURNAL OF MEDICINAL CHEMISTRY | - |
dc.citation.volume | 54 | - |
dc.citation.number | 4 | - |
dc.citation.startPage | 930 | - |
dc.citation.endPage | 938 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Medicinal | - |
dc.subject.keywordPlus | L-HOMOCYSTEINE HYDROLASE | - |
dc.subject.keywordPlus | CARBOCYCLIC NUCLEOSIDES | - |
dc.subject.keywordPlus | BIOLOGICAL EVALUATION | - |
dc.subject.keywordPlus | DESIGN | - |
dc.subject.keywordPlus | TARGET | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.